Bioenvision Files for Drug OK in Europe (Reuters) Reuters - Bioenvision Inc. (BIVN.O) said on\Friday it has submitted an application to European regulators\to market its experimental leukemia drug. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 